# BlackRock's Biotech Investments: 19 Startups in Its Portfolio (2026) > The 19 Biotech startups BlackRock has backed, by stage: $4.2B raised between them. From the rounds we track; updated nightly. Source: https://millionrounds.com/portfolio-maps/blackrock-biotech-portfolio (Millionrounds; every figure on the page links to its filing or article) ## Series C and later 8 - [Kymera Therapeutics](https://millionrounds.com/company/kymera-therapeutics) - [Cellares](https://millionrounds.com/company/cellares) - [Arcutis Biotherapeutics](https://millionrounds.com/company/arcutis-biotherapeutics) - [Science 37](https://millionrounds.com/company/science-37) - [Decibel Therapeutics](https://millionrounds.com/company/decibel-therapeutics) - [Vividion Therapeutics](https://millionrounds.com/company/vividion-therapeutics) - [Cellarity](https://millionrounds.com/company/cellarity) - [Bright Peak Therapeutics](https://millionrounds.com/company/bright-peak-therapeutics) ## Stage not reported 7 - [Taysha Gene Therapies](https://millionrounds.com/company/taysha-gene-therapies) - [Monte Rosa Therapeutics](https://millionrounds.com/company/monte-rosa-therapeutics) - [OnKure Therapeutics](https://millionrounds.com/company/onkure-therapeutics) - [Caresyntax](https://millionrounds.com/company/caresyntax) - [Elvie](https://millionrounds.com/company/elvie) - [Omega Therapeutics](https://millionrounds.com/company/omega-therapeutics) - [Mirvie](https://millionrounds.com/company/mirvie) ## Series B 4 - [Laronde](https://millionrounds.com/company/laronde) - [Solugen](https://millionrounds.com/company/solugen) - [Annexon Biosciences](https://millionrounds.com/company/annexon-biosciences) - [TScan Therapeutics](https://millionrounds.com/company/tscan-therapeutics) ## Segment by segment ### Series C and later 8 startups · $2.1B raised - [**Kymera Therapeutics**](https://millionrounds.com/company/kymera-therapeutics) Kymera Therapeutics is a biotechnology company that specializes in the field of targeted protein degradation. United States $799M - [**Cellares**](https://millionrounds.com/company/cellares) Cellares is a biotechnology company based in South San Francisco, California, and is recognized as the world’s first Integrated De United States $257M - [**Arcutis Biotherapeutics**](https://millionrounds.com/company/arcutis-biotherapeutics) Arcutis Biotherapeutics is a clinical-stage biopharmaceutical company focused on developing medical dermatology for unmet needs. United States $245M - [**Science 37**](https://millionrounds.com/company/science-37) Science 37 is a clinical research company that facilitates universal participation in clinical trials for patients and providers. United States $236M - [**Decibel Therapeutics**](https://millionrounds.com/company/decibel-therapeutics) Decibel Therapeutics is a hearing company focused on discovering and developing new medicines to protect, repair, and restore hearing. United States $189M - [**Vividion Therapeutics**](https://millionrounds.com/company/vividion-therapeutics) We are bringing more disease-causing targets within the reach of small molecule therapeutics to transform care for patients with d United States $185M - [**Cellarity**](https://millionrounds.com/company/cellarity) Cellarity is a biotechnology therapeutics company based in Somerville, Massachusetts, founded in 2017 by Flagship Pioneering. United States $121M - [**Bright Peak Therapeutics**](https://millionrounds.com/company/bright-peak-therapeutics) Bright Peak Therapeutics is a private biotechnology company founded in 2017, with headquarters in Basel/Allschwil, Switzerland, an Switzerland $90M ### Stage not reported 7 startups · $1.1B raised - [**Taysha Gene Therapies**](https://millionrounds.com/company/taysha-gene-therapies) Taysha Gene Therapies develops treatments to eradicate severe and life-threatening monogenic diseases of the central nervous system. United States $400M - [**Monte Rosa Therapeutics**](https://millionrounds.com/company/monte-rosa-therapeutics) Monte Rosa Therapeutics is a biotechnology company that develops cancer therapeutics that modulate protein degradation pathways. Switzerland $300M - [**OnKure Therapeutics**](https://millionrounds.com/company/onkure-therapeutics) OnKure is a clinical-stage biopharma company developing precision medicines targeting validated cancer drivers. United States $150M - [**Caresyntax**](https://millionrounds.com/company/caresyntax) Caresyntax is a healthcare technology company founded in 2013, specializing in surgical intelligence. United States $144M - [**Elvie**](https://millionrounds.com/company/elvie) Elvie is a femtech company that specializes in developing innovative technology to support women's health and wellness. United Kingdom $54M - [**Omega Therapeutics**](https://millionrounds.com/company/omega-therapeutics) Omega Therapeutics offers a proprietary epigenomic programming platform. United States $40M - [**Mirvie**](https://millionrounds.com/company/mirvie) Mirvie is a biotechnology company based in South San Francisco, California, focused on improving pregnancy health through early de United States $24M ### Series B 4 startups · $944M raised - [**Laronde**](https://millionrounds.com/company/laronde) Laronde develops an eRNA-based therapeutic platform that is capable of indicating diverse proteins inside the body. United States $440M - [**Solugen**](https://millionrounds.com/company/solugen) Discover the realm of digital intimacy where connections transcend physical boundaries. United States $246M - [**Annexon Biosciences**](https://millionrounds.com/company/annexon-biosciences) Annexon Biosciences is a biotech company, discovering and developing novel therapeutics for neurodegenerative and autoimmune disorders. United States $180M - [**TScan Therapeutics**](https://millionrounds.com/company/tscan-therapeutics) TScan Therapeutics is a biopharmaceutical company focused on the development of immunotherapy treatments for cancer. United States $78M **How this map is made.** Every startup here works in Biotech and has raised money in a round we track that names BlackRock as an investor. Each sits under the stage of its latest round. Rebuilt nightly; updated 15 November 2026. ## More portfolio maps [All portfolios](https://millionrounds.com/portfolio-maps) [Sector portfolio **BlackRock's AI portfolio** 41 startups · $529B](https://millionrounds.com/portfolio-maps/blackrock-ai-portfolio)[Sector portfolio **BlackRock's Fintech portfolio** 25 startups · $17B](https://millionrounds.com/portfolio-maps/blackrock-fintech-portfolio)[Co-investors **Who invests with BlackRock** 300 co-investors](https://millionrounds.com/portfolio-maps/blackrock-co-investors)[Portfolio map **BlackRock portfolio map** 145 startups · $585B](https://millionrounds.com/portfolio-maps/blackrock-portfolio-map)[Sector portfolio **Perceptive Advisors' Biotech portfolio** 101 startups · $24B](https://millionrounds.com/portfolio-maps/perceptive-advisors-biotech-portfolio)[Sector portfolio **Perceptive Advisors' Pharma portfolio** 18 startups · $2.5B](https://millionrounds.com/portfolio-maps/perceptive-advisors-pharma-portfolio) ## Raising from investors like BlackRock? Find the investors who back startups like yours, with their cheques, rounds and partners, in the app with filters, lists and exports. [Find investors](https://millionrounds.com/login?join=1&next=/app/investors)[Market maps](https://millionrounds.com/market-maps)